Dr. Katie Eichinger PharmD, PhD Joins Team as Director of Operations.

With manufacturing, non-clinical studies and regulatory filings all ongoing, Duo Oncology is expanding its full-time team.

Duo Oncology is pleased to announce a $1M+ seed investment led by UPMC oncologists Dr. Stanley Marks and Dr. Jing-Zhou Hou.

LifeX Labs welcomes new portfolio company, Duo Onoclogy, into incubator program.

Duo Oncology is pleased to welcome Dr. Stanley Marks to its board of directors. Dr. Marks is a world renown oncology and chairman of the UPMC Hillman Cancer Center.

Duo Oncology signed an option to exclusively license nanoparticle prodrug chemistry patented developed in the laboratory of Dr. Song Li and patented by the University of Pittsburgh